Joseph E. Eid

Joseph E. Eid has a vast work experience spanning several companies and roles. Joseph E. currently serves as the President of Research and Development at Dragonfly Therapeutics, Inc. and is a Board Member of Angle PLC. Joseph has also held positions as a Board Member of the ALSAC Board of Directors at St. Jude Children's Research Hospital and as a Board Member of the Saint Jude Board of Governors.

Prior to these positions, Joseph served as the EVP and Chief Medical Officer at Luzsana Biotechnology, where they were responsible for the development and management of early and late-stage assets across various therapeutic areas. Joseph E. was also previously the Senior Vice President and Head of Global Medical Affairs at Bristol-Myers Squibb, overseeing a global organization focused on patient health outcomes and the safe use of medicines.

Before their time at Bristol-Myers Squibb, Joseph held various leadership positions at Merck, including Vice President and Head of Oncology Global Medical Affairs, where they built and led the global oncology medical affairs organization. Joseph E. also worked at Roche as a Clinical Science Leader and Clinical Team Leader in global drug development.

Joseph's early career includes roles at Rutgers Robert Wood Johnson Medical School as an Assistant Professor and Hematology/Oncology Fellow, as well as at Staten Island University Hospital as a Resident in Internal Medicine.

Overall, Joseph E. Eid's work experience demonstrates their extensive knowledge and experience in the pharmaceutical and biotechnology industries, particularly in medical affairs, clinical research, and strategy development.

Joseph E. Eid completed their Bachelor of Experimental Sciences degree at Antonins' Fathers College in Baabda, Lebanon from 1970 to 1985. After that, they pursued their medical education at Saint Joseph University, Faculty of Medicine in Beirut, Lebanon from 1985 to 1993 and earned the degree of Doctor of Medicine (MD) with a specialization in Medicine.